MitraClip for severe symptomatic mitral regurgitation in patients at high surgical risk: A comprehensive systematic review

Conclusion: Based on high risk MC studies and high risk MVS data predominantly from STS database, patients with severe MR who are at HSR can be effectively treated with MC or MVS. MitraClip can be safely implanted in high risk patients with relatively low morality and stroke risk. © 2014 Wiley Periodicals, Inc.

Source: Catheterization and Cardiovascular Interventions - June 6, 2014 Category: Cardiovascular & Thoracic Surgery Authors: Femi Philip, Ganesh Athappan, E. Murat Tuzcu, Lars G. Svensson, Samir R. Kapadia Tags: Original Study Source Type: research